Telmisartan/hydrochlorothiazide-induced nevus-associated cutaneous melanoma: first report in the medical literature

References

• Sipahi I, Debanne SM, Dy R, et al. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol. 2010 Jul;11(7):627–636. Epub 2010 Jun 11. PMID: 20542468; PMCID: PMC4070221.
   PubMed Web of Science ®Google Scholar
• Tchernev G, Temelkova I. Valsartan Induced Melanoma?! First Description in Medical Literature! Open Access Maced J Med Sci. 2018 Dec 18;6(12):2378–2380. PMID: 30607196; PMCID: PMC6311487.
   PubMedGoogle Scholar
• Tchernev G, Poterov G. Drug induced cancers: simultaneously development of cutaneous melanoma, colon carcinoma and kaposi sarcoma under valsartan/hydrochlorothiazide. Clin Res Dermatol Open Access. 2020;7(4):1–8.
   Google Scholar
• Daniels B, Pearson SA, Vajdic CM, et al. Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study. Basic Clin Pharmacol Toxicol. 2020 Oct;127(4):320–328. Epub 2020 Aug 3. PMID: 32608576.
   PubMed Web of Science ®Google Scholar
• Schmutz JL. L’hydrochlorothiazide augmenterait le risque de mélanome [Hydrochlorothiazide appears to increase risk of melanoma]. Ann Dermatol Venereol. 2018 Oct;145(10):643–644. Epub 2018 Aug 10. PMID: 30104018.
   PubMedGoogle Scholar
• Pottegård A, Pedersen SA, Schmidt SAJ, et al. Association of hydrochlorothiazide use and risk of malignant melanoma. JAMA Intern Med. 2018 Aug 1;178(8):1120–1122. PMID: 29813157; PMCID: PMC6143099.
   PubMed Web of Science ®Google Scholar
• Olschewski DN, Hofschröer V, Nielsen N, et al. The angiotensin II Type 1 receptor antagonist losartan affects NHE1-dependent melanoma cell behavior. Cell Physiol Biochem. 2018;45(6):2560–2576. Epub 2018 Mar 16. PMID: 29558744.
   PubMedGoogle Scholar
• Renziehausen A, Wang H, Rao B, et al. The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention. Oncogene. 2019 Mar;38(13):2320–2336. Epub 2018 Nov 26. PMID: 30478450.
   PubMed Web of Science ®Google Scholar
• Tchernev G, Poterov G, Malev V. Sartans and melanoma: valsartan induced multiple primary cutaneous melanomas: first description in the medical literature! Clin Res Dermatol Open Access. 2020;7(4):1–3.
   Google Scholar
• Tchernev G, Temelkova I. Valsartan/hydrochlorothiazide induced prostate carcinoma in a patient who subsequently developed melanoma. J Biol Regul Homeost Agents. 2019 Jul-Aug;33(4):1125–1127. PMID: 31079442
   PubMed Web of Science ®Google Scholar
• Tchernev G, Cardoso JC, Poterov G. Sartan means cancer: valsartan induced nevus associated cutaneous melanoma. J Medical Review (Bulgarian). 2020;56(6):59–64.
   Google Scholar
• Tchernev G, Temelkova I. Olmesartan/valsartan induced giant achromatic cutaneous melanoma: “modified” one-step surgical approach with favourable outcome. J Biol Regul Homeost Agents. 2019 Nov-Dec;33(6):1775–1777. PMID: 31538438
   PubMed Web of Science ®Google Scholar
• Tchernev G, Poterov G. Antihypertensive drugs and cancer: simultaneously development of choroidal melanoma and colon carcinoma after administration with valsartan/hydrochlorothiazide. Clin Res Dermatol Open Access. 2020;7(4):1–4.
   Google Scholar
• Tchernev G, Temelkova I. Drug-induced melanoma: Irbesartan induced cutaneous melanoma! First description in the world literature! Open Access Maced J Med Sci. 2019 Jan 9;7(1):114–116. PMID: 30740172; PMCID: PMC6352467.
   PubMedGoogle Scholar
• Tchernev G, Temelkova I. Irbesartan induced cutaneous melanoma! Second case in the medical literature! Open Access Maced J Med Sci. 2019 Jan 9;7(1):121–123. PMID: 30740174; PMCID: PMC6352483.
   PubMedGoogle Scholar
• Siljee S, Pilkington T, Brasch HD, et al. Cancer stem cells in head and neck metastatic malignant melanoma express components of the renin-angiotensin system. Life (Basel). 2020 Nov 2;10(11):268. PMID: 33147716; PMCID: PMC7694034.
   Web of Science ®Google Scholar
• Martens MC, Seebode C, Lehmann J, et al. Photocarcinogenesis and skin cancer prevention strategies: an update. Anticancer Res. 2018 Feb;38(2):1153–1158. PMID: 29374752.
   PubMed Web of Science ®Google Scholar
• Loureiro JB, Abrantes M, Oliveira PA, et al. P53 in skin cancer: from a master player to a privileged target for prevention and therapy. Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188438. Epub 2020 Sep 24. PMID: 32980466.
   PubMed Web of Science ®Google Scholar
• Lin WM, Luo S, Muzikansky A, et al. Outcome of patients with de novo versus nevus-associated melanoma. J Am Acad Dermatol. 2015 Jan;72(1):54–58. Epub 2014 Oct 18. PMID: 25440436.
   PubMed Web of Science ®Google Scholar
• Pampena R, Kyrgidis A, Lallas A, et al. A meta-analysis of nevus-associated melanoma: prevalence and practical implications. J Am Acad Dermatol. 2017 Nov;77(5):938–945.e4. Epub 2017 Aug 29. PMID: 28864306.
   PubMed Web of Science ®Google Scholar
• Tchernev G, Lozev I, Temelkova I, et al. Schizophrenia as Potential Trigger for Melanoma Development and Progression! The Psycho-Neuro-Endocrine-Oncology (P.N.E.O) Network! Open Access Maced J Med Sci. 2018 Aug 16;6(8):1442–1445. PMID: 30159073; PMCID: PMC6108806.
   PubMedGoogle Scholar
• Malev V, Tchernev G. Schizophrenia and Parkinson’s disease as risk factors for melanoma development and progression! Clin Res Dermatol Open Access. 2020;7(3):1–3.
   Google Scholar
• Ryu HJ, Park JH, Choi M, et al. Parkinson’s disease and skin cancer risk: a nationwide population-based cohort study in Korea. J Eur Acad Dermatol Venereol. 2020 Apr 14. Epub ahead of print. PMID: 32289877. DOI:10.1111/jdv.16462.
   PubMed Web of Science ®Google Scholar
• Moriarty N, Moriarty J. Highlighting the link between Parkinson’s disease and malignant melanoma: a case report and literature review. Eur J Case Rep Intern Med. 2019 Oct 21;6(11):001297. PMID: 31890713; PMCID: PMC6886632.
   PubMedGoogle Scholar
• Schmidt SA, Schmidt M, Mehnert F, et al. Use of antihypertensive drugs and risk of skin cancer. J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1545–1554. Epub 2015 Jan 15. PMID: 25640031.
   PubMed Web of Science ®Google Scholar
• Sable K, Majewski S, Nardone B, et al. Association of melanoma and nonmelanoma skin cancer with antihypertensive drugs: A report from the research on adverse drug events and reports project. Poster 3167. J Am Acad Dermatol. 2016 May;74(5):AB221.
   Web of Science ®Google Scholar
• Nardone B, Majewski S, Kim AS, et al. Melanoma and non-melanoma skin cancer associated with angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers and thiazides: a matched cohort study. Drug Saf. 2017 Mar;40(3):249–255. PMID: 27943160.
   PubMed Web of Science ®Google Scholar